Skip to main content
Top
Published in: Acta Diabetologica 1/2011

01-03-2011 | Original Article

Long-term predictive power of heart rate variability on all-cause mortality in the diabetic population

Authors: Ole May, Hanne Arildsen

Published in: Acta Diabetologica | Issue 1/2011

Login to get access

Abstract

To examine the long-term predictive power of heart rate variability (HRV) on all-cause mortality in randomly selected diabetic individuals. A total of 240 diabetic persons were randomly selected from the diabetic population. A 24-h ECG was obtained for each person included and analysed on the Pathfinder 700. In the RR Tools Program time (SDNN, SDANN, SDNN index, RMSSD, NN50, Triangular index) and frequency domain parameters (total power, VLF, LF, LFnorm, HF, HFnorm, HF/LF) were computed. After 15½ years vital statistics were obtained. The analysis included 165 persons with acceptable ECG recordings. 81 individuals (49%) died during follow-up. Correcting for age and gender we found that in time domain, only the SDNN index was a significant mortality predictor but in the frequency domain, all parameters were significantly associated with death. In multivariate analysis only the power in the low frequency band was an independent predictor. During the period following the first 5 years, the baseline LF continued to be a significant predictor of mortality. This long-term follow-up study indicates that the LF power is the strongest HRV predictor with regard to mortality. A reduced HRV at baseline still holds prognostic information after 5 years.
Literature
1.
go back to reference Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579PubMedCrossRef Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579PubMedCrossRef
2.
go back to reference Ewing DJ, Campbell IW, Clarke BF (1980) The natural history of diabetic autonomic neuropathy. Q J Med 49:95–108PubMed Ewing DJ, Campbell IW, Clarke BF (1980) The natural history of diabetic autonomic neuropathy. Q J Med 49:95–108PubMed
3.
go back to reference Maser RE, Mitchell BD, Vinik AI, Freeman R (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 26:1895–1901PubMedCrossRef Maser RE, Mitchell BD, Vinik AI, Freeman R (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 26:1895–1901PubMedCrossRef
4.
go back to reference Gæde P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393PubMedCrossRef Gæde P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393PubMedCrossRef
5.
go back to reference DCCT-investigators (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef DCCT-investigators (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
6.
go back to reference Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC et al (1997) Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 20:355–361PubMedCrossRef Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC et al (1997) Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 20:355–361PubMedCrossRef
7.
go back to reference Laczy B, Cseh J, Mohás M, Markó L, Tamaskó M, Köszegi T et al (2009) Effects of pentoxifylline and pentosa polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus. Acta Diabetol 46:105–111PubMedCrossRef Laczy B, Cseh J, Mohás M, Markó L, Tamaskó M, Köszegi T et al (2009) Effects of pentoxifylline and pentosa polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus. Acta Diabetol 46:105–111PubMedCrossRef
8.
go back to reference Boulton AJM, Vinik AI, Arrezzo JC, Bril V, Feldman EL, Freeman R et al (2005) Diabetic neuropathies. Diabetes Care 28:956–962PubMedCrossRef Boulton AJM, Vinik AI, Arrezzo JC, Bril V, Feldman EL, Freeman R et al (2005) Diabetic neuropathies. Diabetes Care 28:956–962PubMedCrossRef
9.
go back to reference Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. B M J 285:916–918CrossRef Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. B M J 285:916–918CrossRef
10.
11.
go back to reference Pagani M (2000) Heart rate variability and autonomic diabetic neuropathy. Diabetes Nutr Metab 13:341–346PubMed Pagani M (2000) Heart rate variability and autonomic diabetic neuropathy. Diabetes Nutr Metab 13:341–346PubMed
12.
go back to reference May O, Arildsen H, Damsgaard EM, Mickley H (1997) Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc Res 34:241–247PubMedCrossRef May O, Arildsen H, Damsgaard EM, Mickley H (1997) Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc Res 34:241–247PubMedCrossRef
13.
go back to reference WHO study group (1985). Diabetes mellitus. World Health Organisation, Technical Report Series, Geneva 727 WHO study group (1985). Diabetes mellitus. World Health Organisation, Technical Report Series, Geneva 727
14.
go back to reference Task Force ESC, NASPE (1996) Heart rate variability. Standards of measurements, physiological interpretation, and clinical use. Circulation 93:1043–1065 Task Force ESC, NASPE (1996) Heart rate variability. Standards of measurements, physiological interpretation, and clinical use. Circulation 93:1043–1065
15.
go back to reference Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to beat cardiovascular control. Science 213:220–223PubMedCrossRef Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to beat cardiovascular control. Science 213:220–223PubMedCrossRef
16.
go back to reference Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovascular neural regulation explored in the frequency domain. Circulation 84:482–492PubMed Malliani A, Pagani M, Lombardi F, Cerutti S (1991) Cardiovascular neural regulation explored in the frequency domain. Circulation 84:482–492PubMed
17.
go back to reference Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P et al (1986) Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dag. Circ Res 59:178–193PubMed Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P et al (1986) Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dag. Circ Res 59:178–193PubMed
18.
go back to reference Ewing DJ, Clarke BF (1986) Diabetic autonomic neuropathy: present insights and future prospects. Diabetes Care 9:648–665PubMed Ewing DJ, Clarke BF (1986) Diabetic autonomic neuropathy: present insights and future prospects. Diabetes Care 9:648–665PubMed
19.
go back to reference Valensi P, Sachs R-N, Harfouche B, Lormeau B, Paries J, Cosson E et al (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diab Care 24:339–343CrossRef Valensi P, Sachs R-N, Harfouche B, Lormeau B, Paries J, Cosson E et al (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diab Care 24:339–343CrossRef
20.
go back to reference Orchard TJ, Lloyd CE, Maser RE, Kuller LH (1996) Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemilogy of diabetes complications study. Diab Res Clin Pract 34(suppl):S165–S171CrossRef Orchard TJ, Lloyd CE, Maser RE, Kuller LH (1996) Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemilogy of diabetes complications study. Diab Res Clin Pract 34(suppl):S165–S171CrossRef
Metadata
Title
Long-term predictive power of heart rate variability on all-cause mortality in the diabetic population
Authors
Ole May
Hanne Arildsen
Publication date
01-03-2011
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2011
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-010-0222-4

Other articles of this Issue 1/2011

Acta Diabetologica 1/2011 Go to the issue

Review Article

The IGF system

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.